![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Azaron
2. Histantin
3. Pyribenzamine
4. Tripelennamine
5. Tripelennamine Citrate
6. Tripelennamine Citrate (1:1)
7. Tripelennamine Hydrochloride
8. Tripelennamine Maleate
9. Tripelennamine Maleate (1:1)
10. Tripelennamine Monohydrochloride
11. Vetibenzamin
1. Chlorcyclizine Hcl
2. 1620-21-9
3. Histantin
4. Perazil
5. Di-paralene
6. 14362-31-3
7. Chlorcyclizinium Chloride
8. Eramide
9. Chlorcyclizine Monohydrochloride
10. Chlor Cyclizine Hydrochloride
11. Chlorcyclizine (hydrochloride)
12. Nsc-169496
13. 1-((4-chlorophenyl)(phenyl)methyl)-4-methylpiperazine Hydrochloride
14. Npb7a7874u
15. 1-(p-chlorobenzhydryl)-4-methylpiperazine Monohydrochloride
16. 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine;hydrochloride
17. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, Monohydrochloride
18. Ah-289
19. 1620-21-9 (hcl)
20. 1-(p-chloro-alpha-phenylbenzyl)-4-methylpiperazine Monohydrochloride
21. (1-[(4-chlorophenyl)phenyl-methyl]-4-methylpiperazine)
22. Chlorcyclizine Chloride
23. Smr001233306
24. Einecs 238-335-1
25. Nsc 169496
26. Unii-npb7a7874u
27. Chlorcylizine
28. 1-[(4-chlorophenyl)(phenyl)methyl]-4-methylpiperazine Hydrochloride
29. Sr-05000001920
30. Chlorcyclizine Hydrochloride [usp]
31. Prestwick_967
32. Component Of Fedrazil
33. Ah-289 Hydrochloride
34. Diparalene Hydrochloride
35. Ncgc00016589-01
36. Cas-1620-21-9
37. Chlorocyclizine Hydrochloride
38. Dsstox_cid_25360
39. Dsstox_rid_80825
40. Di-paralene Monohydrochloride
41. Dsstox_gsid_45360
42. Mls002153967
43. Mls006010796
44. Schembl321657
45. Chembl1889091
46. Dtxsid7045360
47. Hms1570m13
48. Pharmakon1600-01500175
49. 1-(p-chloro-alpha-phenylbenzyl)-4-methylpiperazine Hydrochloride
50. Chlor Cyclizine-[d4] Hydrochloride
51. Tox21_110511
52. Mfcd00035329
53. Nsc169496
54. Nsc756678
55. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, Hydrochloride
56. Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-, Hydrochloride
57. Akos022181227
58. Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-, Monohydrochloride
59. Wln: T6m Dntj Dyr&r Dg &gh
60. Ccg-212523
61. Hy-112067a
62. Nsc 756678
63. Nsc-756678
64. Chlorcyclizine Hydrochloride [mi]
65. Wln: T6n Dntj Ayr&r Dg& D &gh
66. Chlorcyclizine Hydrochloride [mart.]
67. Chlorcyclizine Hydrochloride [vandf]
68. Chlorcyclizine Hydrochloride [who-dd]
69. Cs-0062684
70. Ft-0664522
71. Ft-0697779
72. F15109
73. Chlorcyclizine Hydrochloride [ep Monograph]
74. J-009887
75. Sr-05000001920-3
76. Q27284988
77. 1-(p-chlorobenzhydryl)-4-methylpiperazine Hydrochloride
78. 1-((4-chlorophenyl)(phenyl)methyl)-4-methylpiperazinexhydrochloride
79. 1-((4-chlorophenyl)phenylmethyl)-4-methylpiperazine Hydrochloride
80. 1-(p-chloro-.alpha.-phenylbenzyl)-4-methylpiperazine Hydrochloride
81. Chlorcyclizine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
82. 1-((4-chlorophenyl)(phenyl)methyl)-4-methylpiperazine Xhydrochloride
83. 1-(p-chloro-.alpha.-phenylbenzyl)-4-methylpiperazine Monohydrochloride
Molecular Weight | 337.3 g/mol |
---|---|
Molecular Formula | C18H22Cl2N2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
Exact Mass | 336.1160041 g/mol |
Monoisotopic Mass | 336.1160041 g/mol |
Topological Polar Surface Area | 6.5 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 300 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)